These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24508526)

  • 1. Malabaricone C-containing mace extract inhibits safrole bioactivation and DNA adduct formation both in vitro and in vivo.
    Martati E; Boonpawa R; van den Berg JH; Paini A; Spenkelink A; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
    Food Chem Toxicol; 2014 Apr; 66():373-84. PubMed ID: 24508526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologically based biokinetic (PBBK) modeling of safrole bioactivation and detoxification in humans as compared with rats.
    Martati E; Boersma MG; Spenkelink A; Khadka DB; van Bladeren PJ; Rietjens IM; Punt A
    Toxicol Sci; 2012 Aug; 128(2):301-16. PubMed ID: 22588462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo validation and physiologically based biokinetic modeling of the inhibition of SULT-mediated estragole DNA adduct formation in the liver of male Sprague-Dawley rats by the basil flavonoid nevadensin.
    Alhusainy W; Paini A; van den Berg JH; Punt A; Scholz G; Schilter B; van Bladeren PJ; Taylor S; Adams TB; Rietjens IM
    Mol Nutr Food Res; 2013 Nov; 57(11):1969-78. PubMed ID: 23894034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically based biokinetic (PBBK) model for safrole bioactivation and detoxification in rats.
    Martati E; Boersma MG; Spenkelink A; Khadka DB; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
    Chem Res Toxicol; 2011 Jun; 24(6):818-34. PubMed ID: 21446753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect.
    Alhusainy W; Paini A; Punt A; Louisse J; Spenkelink A; Vervoort J; Delatour T; Scholz G; Schilter B; Adams T; van Bladeren PJ; Rietjens IM
    Toxicol Appl Pharmacol; 2010 Jun; 245(2):179-90. PubMed ID: 20226806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo formation of N7-guanine DNA adduct by safrole 2',3'-oxide in mice.
    Shen LC; Chiang SY; Lin MH; Chung WS; Wu KY
    Toxicol Lett; 2012 Sep; 213(3):309-15. PubMed ID: 22820429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytes.
    Paini A; Punt A; Viton F; Scholz G; Delatour T; Marin-Kuan M; Schilter B; van Bladeren PJ; Rietjens IM
    Toxicol Appl Pharmacol; 2010 May; 245(1):57-66. PubMed ID: 20144636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of methyleugenol bioactivation by the herb-based constituent nevadensin and prediction of possible in vivo consequences using physiologically based kinetic modeling.
    Al-Subeihi AA; Alhusainy W; Paini A; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
    Food Chem Toxicol; 2013 Sep; 59():564-71. PubMed ID: 23831728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo validation of DNA adduct formation by estragole in rats predicted by physiologically based biodynamic modelling.
    Paini A; Punt A; Scholz G; Gremaud E; Spenkelink B; Alink G; Schilter B; van Bladeren PJ; Rietjens IM
    Mutagenesis; 2012 Nov; 27(6):653-63. PubMed ID: 22844077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safrole-DNA adduct in hepatocellular carcinoma associated with betel quid chewing.
    Chung YT; Chen CL; Wu CC; Chan SA; Chi CW; Liu TY
    Toxicol Lett; 2008 Dec; 183(1-3):21-7. PubMed ID: 18938230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo genotoxicity and DNA adduct levels in the liver of rats treated with safrole.
    Daimon H; Sawada S; Asakura S; Sagami F
    Carcinogenesis; 1998 Jan; 19(1):141-6. PubMed ID: 9472705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Dynamics and
    Yang S; Liu JDH; Diem M; Wesseling S; Vervoort J; Oostenbrink C; Rietjens IMCM
    Chem Res Toxicol; 2020 Sep; 33(9):2298-2309. PubMed ID: 32786539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and quantification of specific DNA adducts by liquid chromatography-tandem mass spectrometry in the livers of rats given estragole at the carcinogenic dose.
    Ishii Y; Suzuki Y; Hibi D; Jin M; Fukuhara K; Umemura T; Nishikawa A
    Chem Res Toxicol; 2011 Apr; 24(4):532-41. PubMed ID: 21384859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basil extract inhibits the sulfotransferase mediated formation of DNA adducts of the procarcinogen 1'-hydroxyestragole by rat and human liver S9 homogenates and in HepG2 human hepatoma cells.
    Jeurissen SM; Punt A; Delatour T; Rietjens IM
    Food Chem Toxicol; 2008 Jun; 46(6):2296-302. PubMed ID: 18433972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry.
    Gamboa da Costa G; Marques MM; Beland FA; Freeman JP; Churchwell MI; Doerge DR
    Chem Res Toxicol; 2003 Mar; 16(3):357-66. PubMed ID: 12641436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA adduct formation in the livers of female Sprague-Dawley rats treated with toremifene or alpha-hydroxytoremifene.
    Gamboa da Costa G; Pereira PC; Churchwell MI; Beland FA; Marques MM
    Chem Res Toxicol; 2007 Feb; 20(2):300-10. PubMed ID: 17261033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response formation of N7-(3-benzo[1,3]dioxol-5-yl-2-hydroxypropyl)guanine in liver and urine correlates with micronucleated reticulocyte frequencies in mice administered safrole oxide.
    Wu KY; Wei YT; Luo YS; Shen LC; Chang BS; Chen YY; Huang YC; Huang HF; Chung WS; Chiang SY
    Food Chem Toxicol; 2023 Nov; 181():114056. PubMed ID: 37739051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo.
    Tan DX; Pöeggeler B; Reiter RJ; Chen LD; Chen S; Manchester LC; Barlow-Walden LR
    Cancer Lett; 1993 Jun; 70(1-2):65-71. PubMed ID: 8330303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of N(2),3-ethenoguanine in rat brain and liver after exposure to vinyl chloride.
    Morinello EJ; Koc H; Ranasinghe A; Swenberg JA
    Cancer Res; 2002 Sep; 62(18):5183-8. PubMed ID: 12234982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A physiologically based in silico model for trans-2-hexenal detoxification and DNA adduct formation in rat.
    Kiwamoto R; Rietjens IM; Punt A
    Chem Res Toxicol; 2012 Dec; 25(12):2630-41. PubMed ID: 22978292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.